Empreses emergents
2014
XENOPAT SLOferir serveis d'ajuda al desenvolupament de fàrmacs anticancerígens i tractament personalitzat del càncer Serveis preclínics avançats i tractament personalitzat del càncer
Adreça
Carrer de la Feixa Llarga s/n, 08907 L'Hospitalet de Llobregat, Espanya
Propietat CERCA
L'Hospitalet de Llobregat, Spain
2004
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)
Contacte del Centre CERCA
LT
Laia TravesetResponsable innovació
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)Altres accionistes públics catalans
Logotip
Àrees d'estat i deeptech
Estat de l'empresa i àrees de tecnologia profunda de l'empresaEstat de l'empresa
Àrea DeepTech
Informació sobre la spin-off
Descripció de l'empresa
Xenopat is a spin-off company, of the Catalan Institute of Oncology (ICO), the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital (HUB).
Descripció del producte
Advanced Preclinical Services
Xenopat offers researchers and companies devoted to the development of new anticancer drugs, the most innovative tools available. Xenopat offers researchers the OrthoXenoBank®, which is composed of several orthotopic models of different tumor types (orthoxenografts®), characterized at histological and genetic levels, with different sensitivity to diverse chemotherapies.
Personalized Cancer Treatment
Xenopat offers healthcare professionals and patients the most advanced technology in order to select the best treatment in the fight against cancer. Xenopat offers the possibility to generate an orthoxenograft® from a small fragment of the patient’s tumor. This mouse model allows us to test several drugs and find the best therapy for each patient.
Xenopat offers researchers and companies devoted to the development of new anticancer drugs, the most innovative tools available. Xenopat offers researchers the OrthoXenoBank®, which is composed of several orthotopic models of different tumor types (orthoxenografts®), characterized at histological and genetic levels, with different sensitivity to diverse chemotherapies.
Personalized Cancer Treatment
Xenopat offers healthcare professionals and patients the most advanced technology in order to select the best treatment in the fight against cancer. Xenopat offers the possibility to generate an orthoxenograft® from a small fragment of the patient’s tumor. This mouse model allows us to test several drugs and find the best therapy for each patient.